CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 24 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $995,000 | -32.5% | 46,000 | -8.0% | 0.01% | -16.7% |
Q2 2021 | $1,473,000 | +6.8% | 50,000 | 0.0% | 0.01% | -7.7% |
Q1 2021 | $1,379,000 | -18.0% | 50,000 | 0.0% | 0.01% | -35.0% |
Q4 2020 | $1,681,000 | +14.7% | 50,000 | -18.1% | 0.02% | +5.3% |
Q3 2020 | $1,466,000 | -4.2% | 61,084 | -7.4% | 0.02% | -29.6% |
Q2 2020 | $1,531,000 | – | 66,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 144,393 | $4,252,000 | 1.17% |
BVF INC/IL | 750,000 | $22,080,000 | 0.83% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 15,890 | $468,000 | 0.24% |
Vivo Capital, LLC | 62,306 | $1,835,000 | 0.08% |
Pentwater Capital Management LP | 50,000 | $1,473,000 | 0.01% |
NEXT Financial Group, Inc | 4,458 | $131,000 | 0.01% |
Advisory Services Network, LLC | 3,369 | $99,000 | 0.00% |
DEUTSCHE BANK AG\ | 71,531 | $2,107,000 | 0.00% |
JANE STREET GROUP, LLC | 7,216 | $211,000 | 0.00% |
UBS Group AG | 11 | $0 | 0.00% |